ersonal use only
INVESTOR BRIEF
JULY 2022
DISCLAIMER
use only | |
This presentation contains certain "forward-looking statements" concerning Wellfully. Where Wellfully expresses or implies an expectation or belief as to | |
ersonal | |
future events or results, such expectation or belief is expressed in good faith and believed to have a reasonable basis. | |
Forward-looking statements provided in this announcement are based on assumptions and contingencies which are subject to change without notice. | |
Such forward-looking statements including statements regarding intentions, planned events and potential results are provided as a general guide only | |
a d should not be relied upon as an indication or guarantee of future performance. | |
There can be no assurance that actual outcomes will not differ materially from these forward-looking statements, and there are risks associated with | |
Wellfully and the industry which may affect the accuracy of the forward-looking statements. Wellfully does not undertake any obligation to release | |
publicly any revisions to any forward-looking statements to reflect events or circumstances after the date of this announcement or to reflect the | |
occurrence of unanticipated events, except as may be required under applicable securities laws. | |
ASX:WFL - July 2022 | 2 |
WELLFULLY INVESTMENT HIGHLIGHTS
A HIGHLY INNOVATIVE WELLNESS COMPANY WITH GLOBALLY DISRUPTIVE PRODUCTS
About Wellfully Limited (ASX:WFL) | Share Price Performance |
Wellfully Limited ('Wellfully' or 'the Company') is the world's first fully-integrated, | |
only | |
science-based wellness company. Over the past two years, the Company has | |
leveraged its vast enhanced drug deliveries technology inventory and developed | |
industrial infrastructure and its own product portfolio. |
Wellfully is active in the highly attractive beauty and personal care, beauty device, as | |||
well as the health and pain relief markets delivering innovative products through | |||
c llaborations with industry majors spanning licensing, joint development and OEM, | |||
as well as with its own global cosmetic and healthcare brands, RÉDUIT and | |||
SWISSWELL, positioned to disrupt these global blockbuster markets. | |||
Supported by a highly experienced Board and Management, Wellfully is poised to | |||
use | |||
d liver notable and sustainable results. | |||
Corporate Snapshot* | |||
Share Price | $0.04 | ||
Shares on Issue | ~275.2m | ||
Options on Issue | ~201m | ||
ersonal | |||
Market Capitalisation (fully diluted) | ~$11.01m | ||
Cash (as at 31 March 2022) | ~$1.2m | ||
Net Debt | Nil | ||
Top 20 | 40.9% | ||
Board & Management | 7.05% | ||
*Share price, market capitalisation, share holdings as at 20 July 2022 | |||
ASX:WFL - July 2022 | 3 |
AGENDA
INVESTOR CALL 21.7.2022
only | STRATEGY & COMPETITIVE ADVANTAGE | |
• Completion of Third Strategic Pillar | ||
• WFL as a Data Company | ||
• | Consumer Insight Advantages | |
use | FINANCING ACTIVITIES | |
• | Private Placements | |
• | Share Purchase Plan | |
• Equity Facility Draw Down | ||
ersonal | • | New Investors |
OPERATIONS UPDATE | ||
• | Key Focus Area | |
• NPD and Supply-Chain | ||
• | Commercial Activities | |
ASX:WFL - July 2022 | 4 |
CREATING VALUE FOR CONSUMERS AND INVESTORS
THREE PILLARS IN SYNC FOR UNIQUE COMPETITIVE ADVANTAGE
PROPRIETARY
TECHNOLOGIES
only |
+ 360ºINFRASTRUCTUREOPERATIONS + CONSUMERINSIGHTS
- CONTINUOUSLY GENERATING VALUE FOR CUSTOMERS AND INVESTORS
WELLFULLY is the world's first science-based, fully vertically-integrated wellness company.
The company is scaling its proprietary enhanced drug delivery know-how developed over the past
25 years, across a multitude of beauty, health and wellness applications.
With its own in-house ability to develop,
use | ENHANCED DRUG |
DELIVERY, the proven | |
ability to move active | |
ingredients from | |
formulations to where | |
they are needed in a | |
ersonal | controlled way |
+25 years of research with global majors
+17 patents covering key company technologies
ASX:WFL - July 2022
FULLY VERTICALLY INTEGRATED operation
spanning:
- Product & process R&D
- Industrialisation
- Formulations creation
- Device manufacturing
- Distribution & MKTG
- In-housebrands
GMP Certified
formulations plant SWISS Made topical production
THE ONLY UNIVERSAL POINT-OF-USE APP
across health and beauty
applications for 3rd party topical products available today:
- Active for over 1 million formulations - still growing perimeter
- Visibility of all relevant consumer parameters - based on applications
+23,000 parameters for
different applications
+33 unique active
ingredients covered with tailored waveforms
manufacture and market products through own brands and distribution networks, WELLFULLY has outstanding time-to-market,control of innovation, supply-chain,quality - as well as operative margins.
Last, but not least, WELLFULLY has made its specialization in the delivery of its assets in terms
of data management, and is currently the only company gathering point-of-useinformation across 1.000s of 3rd party topical products used by its consumers around the globe.
Through superior consumer insights,
WELLFULLY is understanding its customers better, and able to close the loop in value creation and propose even better innovation and products, as well as market these more effectively.
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Wellfully Ltd. published this content on 21 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 July 2022 02:53:00 UTC.